Neuropeptides
Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials
Bornstein NM, Guekht A, Vester J, et al. · Neurol Sci · 2018
PMID: 28656143 · DOI: 10.1007/s10072-017-3036-0
Summary
Meta-analysis of nine randomized controlled trials (n=1879) of cerebrolysin in acute ischemic stroke. Endpoints: NIHSS at day 30, mortality, adverse-event rates.
Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.
More Neuropeptides citations
- Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trialStroke · 2012
- Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurastheniaZh Nevrol Psikhiatr Im S S Korsakova · 2007
- The efficacy of semax in the treatment of patients at different stages of ischemic strokeZh Nevrol Psikhiatr Im S S Korsakova · 2018